“Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series”, Indian J Case Reports, vol. 7, no. 11, pp. 469–472, Nov. 2021, doi: 10.32677/ijcr.v7i11.3107.